Advancing Breakthroughs in Cancer Research
Advances in cell analysis, genomics, metabolic studies, protein profiling, and pathology are revealing new connections in our understanding of cancer and a comprehensive picture.From new understandings of tumor genomic microheterogeneity, to powerful and precise therapies such as immune checkpoint inhibitors.必威体育登录手机It's an exciting time to be researching breakthroughs that could affect many lives. Whether your early discovery research, clinical trials or diagnostic tools development, Agilent is there to support scientists with an integrated portfolio of solutions.
必威体育登录手机Agilent Press Presentation at AACR
-
For additional information on the content of this presentation, or to connect with any of the presenters contact Naomi Goumillout at必威体育登录手机naomi.goumillout@agilent.com
View presentation (pdf)
必威体育登录手机Agilent Press Conference Presenters
-
Todd Christian必威体育登录手机- Vice President and General Manager, Cell Analysis Division, Agilent Technologies
Roddy O'Connor- BSc, MS, Ph.D., Research Assistant Professor of Pathology & Laboratory Medicine, Perelman School of Medicine, U.Pennsylvania
Pradipta Ghosh- M.D., Professor, Medicine and Cellular and Molecular Medicine, UC San Diego
San Diego Zoo Wildlife Alliance
-
The San Diego Zoo in California is a renowned zoological park, dedicated to conservation efforts, education, and public engagement related to wildlife and endangered species.必威体育登录手机The San Diego Zoo Wildlife Alliance utilizes flow cytometry instruments from Agilent in their research.Flow cytometry is a powerful technique used for analyzing and sorting cells based on their physical and chemical properties.It allows researchers to examine individual cells, assess cell populations, and study various biological processes.
Next Generation Solutions for Cell Therapies
-
Explore solutions for cell engineering, immunophenotyping, and high-throughput screening of optimal engineered immune cells.The success of cell therapies depends on selective engineering of immune cells followed by extensive ex-vivo characterization to identify the optimal candidate.
Next Generation Solutions Featured at AACR 2024
-
-
必威体育登录手机Agilent NovoCyte Opteon Spectral Flow Cytometer
必威体育登录手机The Agilent NovoCyte Opteon Spectral Flow Cytometer, is an advanced solution in spectral flow cytometry.This user-friendly system allows simultaneous analysis of multiple markers and offers flexibility in designing multiple marker panels.With configurations ranging from 3 to 5 lasers and support for up to 70 high-quality detectors, the NovoCyte Opteon promises enhanced research capabilities for scientists and researchers.
-
必威体育登录手机Agilent Avida
必威体育登录手机Agilent Avida's new cutting-edge target enrichment solutions enable simultaneous DNA and methylation profiling from a single sample.The proprietary Avida technology maintains original sample quality and quantity, supporting advanced applications such as liquid biopsy and multiomics capabilities for targeted next-generation sequencing (NGS).Researchers gain accelerated access to genetic and epigenetic data from limited samples, propelling cancer biology and clinical insights.The high-performance and streamlined workflows offer outstanding fidelity, turnaround time, and ease of use.
-
必威体育登录手机Agilent SureSelect Cancer Custom panels
必威体育登录手机Agilent SureSelect Cancer Custom panels offer the ability to add new and emerging biomarkers, including tumor mutational burden (TMB) and microsatellite instability (MSI), to custom tumor genomic profiling assays.必威体育登录手机These custom NGS cancer panels are designed quickly and easily using Agilent SureDesign 8.0, an intuitive probe design software powered by machine learning.必威体育登录手机These custom cancer panels extend the SureSelect Cancer product portfolio and underscore Agilent's commitment to advancing precision oncology.
-
必威体育登录手机Agilent SureSelect CD CiberMed Tissue and SureSelect CD CiberMed Heme panels
必威体育登录手机Agilent announces a new partnership with CiberMed.This company aims to simplify cellular profiling and biomarker discovery with its digital cytometry software, iSort.必威体育登录手机The new Agilent SureSelect CD CiberMed Tissue and SureSelect CD CiberMed Heme panels enable a combined SureSelect and iSort workflow to offer a cellular profiling solution from bulk RNA-Seq data with enhanced sensitivity, accuracy, and robustness.
- URL coming soon
-
必威体育登录手机Agilent Cancer Research Solutions
-
-
Cell Analysis
Investigate dynamic cancer cell strategies with innovative cell analysis technologies.
-
-
-
Genomics
必威体育登录手机Agilent's cancer genomic research solutions provide accurate data, insights, and enhanced productivity while improving your ability to deliver trusted answers to your critical challenges.
-
-
-
Biomarkers
Precision medicine has created a need for new cancer biomarkers for sample stratification, compound response, biobanked tissue, and disease understanding.
-
-
-
Diagnostics
必威体育登录手机Agilent builds on 50+ years of experience and cutting-edge diagnostic research to ensure a precisely calibrated assay for each companion therapy.
-
-
-
Companion Diagnostics
必威体育登录手机Agilent's pharmDx solution is a portfolio of all-in-one pharmDx kits that lead to optimal diagnostic results within companion diagnostics.
-
-
-
Biologics
Improve efficiency and increase confidence in biopharmaceutical discovery and development.
-
